Tandem Diabetes Care Inc at Nasdaq Virtual Investor Conference Transcript
Good morning, everyone. I'm Dylan James, Vice President of the Western region here at Nasdaq.
Pleased to welcome the team from Tandem Diabetes this morning. So joining us is John Sheridan, President and CEO of the business; and joining John is Leigh Vosseller, CFO. (Operator Instructions)
And so without any further ado, John, I'm going to go ahead and pass it over to you. Excited to hear the presentation this morning. And thanks very much for joining us.
Absolutely. Thank you, Dylan. And thanks to Nasdaq for having us. It's been a great conference so far.
Well, I just want to start off by saying that Tandem has had a very strong third quarter. We had record sales. We had 30% -- or 31% year-over-year growth, and it turns out that our domestic growth was 25% quarter-over-quarter. We saw the strength really in Control-IQ. The product has just been amazing. We also had the benefit of a full quarter
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |